Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA PerspectiveAndrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon, et al.
Journal of the National Cancer Institute|April 5, 2014
Multiple myeloma in the very old: an IASIA conference reportSascha A Tuchman, Gary R Shapiro, William B Ershler, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Cancer Discovery|December 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug DevelopmentJoshua M Donaldson, Marjilla Seddiq, Michael J Fusco, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug RegistrationKenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.
Pageof 3